Delivery Order SPE2DB24D1107-SPE2DB25FZGT8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $3,977.47. This contract represents a firm fixed-price delivery order under a competitive, non-set-aside procurement and is scheduled for completion by July 25, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office and serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $43,308.34. This firm fixed-price delivery order, without set-aside designation, represents a competitive award under an open solicitation process. The contract is scheduled for completion by September 22, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $1,368.56. This is a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and represents a non-competitive set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) with a ceiling value of $46,869.28. This firm fixed-price delivery order, with an ultimate completion date of September 29, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $16,088.68. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by September 9, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Myrbetriq ER 50 mg tablets in a 90-count configuration, with a ceiling value of $6,187.69. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count packaging) with a contract value of $6,041.02. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $18,945.55. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 28, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) valued at $10,076.28. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $10,190.42. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award to support federal medical procurement needs. The order is set for ultimate completion by July 17, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB24D1107Indefinite Delivery Contract
- SPE2DB24D1107-SPE2DB25FZGT8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $26,034.70. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 29, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating open competition among qualified vendors. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical prime vendor agreement valued through December 2026 that supports global military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a broad portfolio of brand-name and generic medications, vaccines, and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The Myrbetriq supply fulfills medication needs within the military medical supply chain's therapeutic pharmaceutical portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.0k | 9/26/25 |